Total : 6 View more »
Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies.
http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-01-2009/0005086048&EDATE=
Volcano Corporation Presentation at BIOCOM Investor Conference to Be Webcast.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m.
Total : 11 View more »
SAN DIEGO, Nov 24, 2009 /PRNewswire-FirstCall via COMTEX/ --
Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 11 a.m., Eastern Standard Time (8 a.m., Pacific Standard Time).
The presentation will be available through the conference website at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=2539149 and via the company's website at www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation
http://www.volcanocorp.com
Tags: ceo conference disease health heart disease industrial manufacturer nasdaq optical president products sales structural technology telecommunications
Companies: Volcano Corp (VOLC)
SAN DIEGO, Nov 09, 2009 /PRNewswire-FirstCall via COMTEX/ --
Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Third Annual Canaccord Cardiovascular Conference on Tuesday, November 10.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 1 p.m., Pacific Standard Time (4 p.m., Eastern Standard Time).
The presentation will be available through the conference website at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2843940 and via the company's website at www.volcanocorp.com.
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, laser and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation
http://www.volcanocorp.com
Tags: cardiovascular ceo conference disease heart disease industrial manufacturer nasdaq optical president products sales structural technology telecommunications
Companies: Volcano Corp (VOLC)
SAN DIEGO, Oct 21, 2009 /PRNewswire-FirstCall via COMTEX/ --
Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the BIOCOM Investor Conference on Monday, October 26.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 4:30 p.m., Pacific Daylight Time (7:30 p.m., Eastern Daylight Time).
The presentation will be available through the conference website at http://cc.talkpoint.com/bcom001/102609a_me/?entity=4_MFEJRB8 and via the company's website at www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R), Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,000 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens Networks, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation
http://www.volcanocorp.com
Tags: ceo disease heart disease industrial manufacturer nasdaq optical president products sales structural technology telecommunications
Companies: Volcano Corp (VOLC)
Oct 26, 2009 (Wall Street Horizon via COMTEX) --
Volcano Corporation (VOLC)
Expected next earnings release: Announcement date: 11/5/2009 - After Market Earnings Quarter: Q3 Announcement Status: Verified
Expected next investor conference call information: Conference Call Date: 11/5/2009 Conference Call Time (ET): 5:00 PM Conference Call URL: http://ir.volcanocorp.com/eventdetail.cfm?eventid=73296
Tags: conference corporate earnings market
Companies: Volcano Corp (VOLC)
Total : 10 View more »
Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
75% of blindness worldwide is avoidable. Help prevent blindness and restore sight with a donation to www.orbis.org.uk. Give medical aid to those affected by war, natural disasters and poverty through Medicin Sans Frontiers: www.msf.org/
Volcano Corporation develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies.
Volcano Corporation - Financial and Strategic Analysis Review Summary Volcano Corporation is engaged in the development, manufacture and commercialization of a wide range of functional measurement and intravascular ultrasound products.
http://www.researchandmarkets.com/reports/691500/volcano_corporation_financial_and_strategic
Total : 9,380,000 View more »
Volcano Corporation, a Leader in Intravascular Ultrasound (IVUS) & Heart Diagnostic Tools, Produces Cardiac Catherization & Heart Ultrasound Tools, Interventional Guide Wires ...
Be a part of the vdifference! Volcano Corporation is dedicated to developing breakthrough technologies that save people's lives or enhance their current quality of life!
2009 TCT Investor Information. Volcano Corporation develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the ...
All Releases; Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast Nov 9, 2009 20.2 KB : SAN DIEGO, Nov 09, 2009 /PRNewswire-FirstCall via ...
...SAN DIEGO Nov. 9 /- Volcano Corporation (Nasda...The presentation by Scott Huennekens president and chief executive of...The presentation will be available through the conference website at ...Volcano Corporation (Nasdaq: a
...SAN DIEGO Oct. 26 /- Volcano Corporation (Nasd...The company will hold a conference call to discuss its financial resul...The teleconference can be accessed by calling (719) 457-2658 passcode...A replay of the conference call will be available through Thursday